Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma

3 Jul 2020

Abstract excerpt

BACKGROUND: The tumor immune microenvironment is a heterogeneous entity. Gene expression analysis allows us to perform comprehensive immunoprofiling and may assist in dissecting the different components of the immune infiltrate. As gene expression analysis also provides information regarding tumor cells, differences in interactions between the immune system and specific tumor characteristics can also be explored....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32620126
DOI: 10.1186/s12967-020-02436-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinomaPMID 32620126Read ↗

Characterizing heterogeneity of non-small cell lung tumour microenvironment to identify signature prognostic genes.Semantic proximity Read ↗

Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene‐expression–based retrospective studySemantic proximity Read ↗

Immune Infiltration Landscape in Lung Squamous Cell Carcinoma Implications.Semantic proximity Read ↗

Identification of a prognostic immune-related signature for small cell lung cancer.Semantic proximity Read ↗

Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Systematic construction and validation of an immune prognostic model for lung adenocarcinomaSemantic proximity Read ↗

Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancerSemantic proximity Read ↗

Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-SequencingSemantic proximity Read ↗

Deciphering the immune heterogeneity dominated by RGS1+ TAMs with prognostic implications and identification of novel immunotherapeutic biomarker CD83 in lung adenocarcinomaSemantic proximity Read ↗

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.Semantic proximity Read ↗

Comprehensive Analysis of Immune Cell Enrichment In The Tumor Microenvironment of Head And Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Comparing NKp44+ and NKp44− ILC3s in Human Lung Cancer via Transcriptional SequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.